BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3818101)

  • 1. Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis.
    Onderdonk AB; Bronson R; Cisneros R
    Infect Immun; 1987 Mar; 55(3):835-6. PubMed ID: 3818101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus.
    Onderdonk AB; Cisneros RL; Bronson RT
    Infect Immun; 1983 Nov; 42(2):783-8. PubMed ID: 6642651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive transfer of immune enhancement of experimental ulcerative colitis.
    Onderdonk AB; Steeves RM; Cisneros RL; Bronson RT
    Infect Immun; 1984 Oct; 46(1):64-7. PubMed ID: 6480115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteroides vulgatus outer membrane antigens associated with carrageenan-induced colitis in guinea pigs.
    Breeling JL; Onderdonk AB; Cisneros RL; Kasper DL
    Infect Immun; 1988 Jul; 56(7):1754-9. PubMed ID: 3384476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora.
    Onderdonk AB; Franklin ML; Cisneros RL
    Infect Immun; 1981 Apr; 32(1):225-31. PubMed ID: 7216487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of gut inflammation by Bifidobacterium in dextran sulfate-treated gnotobiotic mice associated with Bacteroides strains isolated from ulcerative colitis patients.
    Setoyama H; Imaoka A; Ishikawa H; Umesaki Y
    Microbes Infect; 2003 Feb; 5(2):115-22. PubMed ID: 12650769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenic role of Bacteroides vulgatus in patients with ulcerative colitis.
    Bamba T; Matsuda H; Endo M; Fujiyama Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():45-7. PubMed ID: 8563888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production of erosions and ulcers of the colon in Syrian hamsters with Bacteroides vulgatus isolated from the fecal microflora of human ulcerative colitis].
    Ohkusa T; Fujimoto H; Shikato F; Nishiura M; Nakamura R; Kuyama Y; Hasegawa K; Chida T; Okamura N; Nakaya R
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jan; 82(1):72-7. PubMed ID: 4039383
    [No Abstract]   [Full Text] [Related]  

  • 9. Serogrouping of Bacteroides vulgatus by the agglutination test.
    Okamura N; Miyazaki K; Chida T; Niwayama K; Nakaya R; Benno Y; Mitsuoka T
    J Clin Microbiol; 1985 Jul; 22(1):56-61. PubMed ID: 4019743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model of human disease. Ulcerative colitis. Animal model: Ulcerative colitis induced in guinea pigs with degraded carrageenan.
    Anver MR; Cohen J
    Am J Pathol; 1976 Aug; 84(2):431-4. PubMed ID: 941984
    [No Abstract]   [Full Text] [Related]  

  • 11. The carrageenan model for experimental ulcerative colitis.
    Onderdonk AB
    Prog Clin Biol Res; 1985; 186():237-45. PubMed ID: 4034603
    [No Abstract]   [Full Text] [Related]  

  • 12. OmpA variants affecting the adherence of ulcerative colitis-derived Bacteroides vulgatus.
    Sato K; Kumita W; Ode T; Ichinose S; Ando A; Fujiyama Y; Chida T; Okamura N
    J Med Dent Sci; 2010 Mar; 57(1):55-64. PubMed ID: 20437766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-Specific Bacteroides Genome Variants in Pouchitis.
    Vineis JH; Ringus DL; Morrison HG; Delmont TO; Dalal S; Raffals LH; Antonopoulos DA; Rubin DT; Eren AM; Chang EB; Sogin ML
    mBio; 2016 Nov; 7(6):. PubMed ID: 27935837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of bacterial DNA from Mycobacteria spp., Bacteroides vulgatus, and Escherichia coli in tissue samples from patients with inflammatory bowel diseases.
    Fujita H; Eishi Y; Ishige I; Saitoh K; Takizawa T; Arima T; Koike M
    J Gastroenterol; 2002; 37(7):509-16. PubMed ID: 12162408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrageenan colitis in the guinea pig: pathological changes and the importance of ascorbic acid deficiency in disease induction.
    Langman JM; Rowland R; Vernon-Roberts B
    Aust J Exp Biol Med Sci; 1985 Oct; 63 ( Pt 5)():545-53. PubMed ID: 4091760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of metronidazole in experimental ulcerative colitis.
    Onderdonk AB; Hermos JA; Dzink JL; Bartlett JG
    Gastroenterology; 1978 Mar; 74(3):521-6. PubMed ID: 344126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis.
    Lucke K; Miehlke S; Jacobs E; Schuppler M
    J Med Microbiol; 2006 May; 55(Pt 5):617-624. PubMed ID: 16585651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis.
    Matsuda H; Fujiyama Y; Andoh A; Ushijima T; Kajinami T; Bamba T
    J Gastroenterol Hepatol; 2000 Jan; 15(1):61-8. PubMed ID: 10719749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Model development, histopathology, and effects of sulfasalazine.
    Oestreicher P; Nielsen ST; Rainsford KD
    Dig Dis Sci; 1991 Apr; 36(4):461-70. PubMed ID: 1672517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli.
    Rath HC; Wilson KH; Sartor RB
    Infect Immun; 1999 Jun; 67(6):2969-74. PubMed ID: 10338507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.